Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SUVOREXANT vs TADALAFIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SUVOREXANT vs TADALAFIL: Safety Overview

Metric SUVOREXANT TADALAFIL
Total FAERS Reports 9,413 30,683
Deaths Reported 219 3,553
Death Rate 2.3% 11.6%
Hospitalizations 572 8,717
Average Patient Age 62.6 yrs 58.7 yrs
% Female Patients 62.4% 42.7%
FDA Approval Date Aug 13, 2014 Apr 29, 2019
Manufacturer Merck Sharp & Dohme LLC Guangzhou Yixin Cross-border E-commer...
Route ORAL TOPICAL
Marketing Status Prescription Prescription